Annual report pursuant to Section 13 and 15(d)

Goodwill and Other Intangible Assets (Tables)

v2.4.1.9
Goodwill and Other Intangible Assets (Tables)
 12 Months Ended
Dec. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill [Table Text Block]
A rollforward of the carrying value of goodwill from continuing operations from January 1, 2014 to December 31, 2014 is as follows:
 
2014
 
January 1,
Additions
Adjustments
Impairments
December 31,
RedPath
$
—

$
15,545

$
—

$
—

$
15,545

Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]
The net carrying value of the identifiable intangible assets as of December 31, 2014 is as follows: 
 
 
 
As of December 31, 2014
 
Life
 
Carrying
Accumulated
 
 
(Years)
 
Amount
Amortization
Net
Diagnostic assets:
 
 
 
 
 
Asuragen acquisition:
 
 
 
 
 
   Thyroid
9
 
$
8,519

$
—

$
8,519

   Pancreas
7
 
2,882

154

2,728

   Biobank
4
 
1,575

147

1,428

RedPath acquisition:
 
 
 
 
 
Pancreas test
7
 
16,141

385

15,756

Barrett's test
9
 
18,351

—

18,351

Total
 
 
$
47,468

$
686

$
46,782

Diagnostic lab:
 
 
 
 
 
CLIA Lab
2.3
 
$
609

$
87

$
522

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]
Estimated amortization expense for the next five years is as follows:

2015
2016
2017
2018
2019
$
5,102

$
6,358

$
6,097

$
5,949

$
5,703